Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
Judy JohnsonJudy Johnson, CMP, president, CEO, and co-owner of Plano, Texas–based Rx Worldwide Meetings Inc. since 2000, has sold her medical meeting planning company to Sally and Mike Roberts, both of whom come from the pharmaceutical industry...
According to a PricewaterhouseCoopers benchmarking survey, 85 percent of U.S. pharmaceutical companies have implemented a system to track and report what they spend on healthcare professionals, as required by the Open Payments section of the Affo...
A new guide to the European Federation of Pharmaceutical Industries and Associations’ disclosure code is designed to mitigate any negative effects on medical meetings. Here are some of its recommednations.
Genentech Director of Meeting and Convention Services Michael Mahoney Pharma Forum co-organizers MeetingsNet and CBI are pleased to announce that Genentech Director of Meeting and Convention Services Michael Mahoney will be the chairman for Pharm...
At the Pharma Forum 2014, held in March in Orlando, globalization was one of the main themes. Specifically, how can pharma and medical device companies manage their interactions with healthcare professionals in multiple countries, each of which...
The Centers for Medicare & Medicaid Services believes removing the exemption for accredited CME will make reporting more consistent. Some members of the CME community disagree, arguing that removing the exemption will cause more confusion.
Both meeting professionals and the suppliers who support their events are bumping up against new rules and regulations on the national, state, and company level. We caught up with Marc Eigner, who heads the technology practice for Polaris, at this...
Pharma companies are still struggling with how to comply with Open Payments, formerly known as the Sunshine Act section of the Patient Protection and Affordable Care Act. Here are some practical suggestions that will help.
